Popular on EntSun
- Justin Jeansonne An Emerging Country Singer-Songwriter Music Fans Have Been Waiting For…a True Maverick - 246
- Donna Cardellino Manager/Facilitator Signs Justin Jeansonne Country Singer-Songwriter To Exclusive Management Deal For Global Music Expansion - 156
- VDG Virtuoso Emerges as a New-Model Independent Industry Figure Blending Artist, Executive, and Infrastructure Builder - 149
- Oliver Sean's "Everyday Will Be Like A Holiday" Featuring the Real Indie Project Hits #1 in Portugal on Christmas Eve - 126
- UK Financial Ltd Executes Compliance Tasks Ahead Of First-Ever ERC-3643 Exchange-Traded Token, SMCAT & Sets Date For Online Investor Governance Vote - 125
- Kaltra Launches Next-Gen MCHEdesign With Full Integration Into MCHEselect — Instant Simulation & Seamless Microchannel Coil Workflow - 115
- Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence - 114
- "Phinge Unveil™" Coming to Las Vegas to Showcase Netverse Patented Verified App-less Platform, AI & Modular Hardware Including Developer Conferences - 111
- Renowned Alternative Medicine Specialist Dr. Sebi and His African Bio Mineral Balance Therapy Are the Focus of New Book - 110
- IQSTEL Enters 2026 from a Position of Strength Following Transformational Year Marked by N A S D A Q Uplisting, Record Revenue and First-Ever - 108
Similar on EntSun
- High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
- AI-Driven Drug Development with Publication of New Bioinformatics Whitepaper for BullFrog AI: $BFRG Strengthens Its Position in AI Drug Development
- VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
- High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
- OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
- FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
- Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)
- $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
- $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
- U.S. Entrepreneur Anjo De Heus Builds Innovation Bridge Between America and the Gulf
SNS Research Launches SNS Market Intelligence Platform for visual market intelligence for pharma
EntSun News/11081977
SNS Intel is an Market Intelligence Platform for visual market intelligence across pharmaceutical and healthcare markets currently launching with Dermatology In Sight Module featuring in visual dashboards and Skin Cancer & Psoriasis as Focus areas
PITTSBURGH - EntSun -- SNS Intelligence announced the official launch of the SNS Market Intelligence Platform, a next-generation solution designed to replace static reports with an interactive market intelligence portal. The platform delivers structured market and drug development pipeline data through a cloud-based dashboard featuring advanced filters, slicers, and dynamic visualizations.
SNS Market Intelligence Platform Key Features:
The SNS Market Intelligence Platform consolidates years of proprietary research into a single, unified interface built for biopharma strategy, business development, competitive intelligence, and investment teams. Users can interrogate market size and forecast data by geography, subsegments and at country level. Key pipeline candidates are also presented in a structured graphical format displaying molecule type, mechanism of action, and clinical stage, enabling rapid identification of white-space opportunities and strategic inflection points.
More on EntSun News
The launch is led by a comprehensive Dermatology In Sight module, with two focus areas: Psoriasis & Skin Cancer, and an active expansion roadmap that includes upcoming datasets on Ophthalmology (Retinal and Glaucoma), Cell & Gene Therapies, Biosimilars, and GLP-1 therapies.
Dermatology In Sight Module: Unmatched Visual Granularity
The inaugural Dermatology module provides high-resolution mapping of the global therapeutic market forecasts, segmented by mechanism of action and molecular class to deliver a precise view of competitive dynamics.
Availability and Free Trial
The SNS Market Intelligence Platform is available via annual subscription, with tiered access designed to support both emerging biotech companies and global pharmaceutical organizations. SNS Intelligence is offering a free limited trial to showcase the platforms capabilities. The Dermatology module is now live and available for a free trial via
https://www.snsintel.com/
More on EntSun News
About SNS Intelligence
SNS Intelligence is global market intelligence firm focused exclusively on healthcare and life sciences. By combining deep domain expertise with rigorous data structuring and advanced visualization, SNS Intelligence enables organizations to make informed decisions in complex and rapidly evolving markets.
SNS Market Intelligence Platform Key Features:
- Clinical and late-stage pipeline tracking: Comprehensive tracking of assets from preclinical through pre-registration, structured to support portfolio planning and competitive intelligence.
- Market size estimates and long-term forecasts covering Therapeutic Category, Drug Delivery Route, Drug Type, Distribution Channel, Drug Class, Regional & Country markets
- • Analyze the data using filters, slicers and time ranges to understand the market landscape.
- Visualizations designed to support strategic planning and investment decisions.
The SNS Market Intelligence Platform consolidates years of proprietary research into a single, unified interface built for biopharma strategy, business development, competitive intelligence, and investment teams. Users can interrogate market size and forecast data by geography, subsegments and at country level. Key pipeline candidates are also presented in a structured graphical format displaying molecule type, mechanism of action, and clinical stage, enabling rapid identification of white-space opportunities and strategic inflection points.
More on EntSun News
- Day-to-Day Work of NOLA's Royal Family of Music, The Batistes, Continues Embracing Legacy & Vision
- Mama Vlada Award-Winning Documentary Playing at Historic Kent Theater, Brooklyn February 6–12, 2026
- Shaken, Not Stirred: Joseph Neibich Nybyk on Mixing Hollywood Spectacle with Stand-Up Soul
- Kadesmode Reaches Top 50% of Global Songwriters Following Chart-Topping Debut R&B Music
- NYCSS Wants You to Unlock Your Inner Jedi
The launch is led by a comprehensive Dermatology In Sight module, with two focus areas: Psoriasis & Skin Cancer, and an active expansion roadmap that includes upcoming datasets on Ophthalmology (Retinal and Glaucoma), Cell & Gene Therapies, Biosimilars, and GLP-1 therapies.
Dermatology In Sight Module: Unmatched Visual Granularity
The inaugural Dermatology module provides high-resolution mapping of the global therapeutic market forecasts, segmented by mechanism of action and molecular class to deliver a precise view of competitive dynamics.
Availability and Free Trial
The SNS Market Intelligence Platform is available via annual subscription, with tiered access designed to support both emerging biotech companies and global pharmaceutical organizations. SNS Intelligence is offering a free limited trial to showcase the platforms capabilities. The Dermatology module is now live and available for a free trial via
https://www.snsintel.com/
More on EntSun News
- Boston Corporate Coach™ Sets Global Standard for Executive Chauffeur Services Across 680 Cities
- UK Financial Ltd Announces CoinMarketCap Supply Verification And Market Positioning Review For Regulated Security Tokens SMPRA And SMCAT
- Sharpe Automotive Redefines Local Car Care with "Transparency-First" Service Model in Santee
- BEST DRESSED & RISE AND FALL Premiere January 30 on Cpics.tv
- Gold Viddy Award Honors Voices for Humanity Episode on Education Reform in Ghana
About SNS Intelligence
SNS Intelligence is global market intelligence firm focused exclusively on healthcare and life sciences. By combining deep domain expertise with rigorous data structuring and advanced visualization, SNS Intelligence enables organizations to make informed decisions in complex and rapidly evolving markets.
Source: SNS Research
0 Comments
Latest on EntSun News
- CryptaBox Introduces a Hardware Crypto Cold Storage Wallet
- YWWSDC Launches AI-Native Digital Asset Infrastructure, Merging Technical Innovation with US-Standard Compliance
- NYC Comedian Rafael Gee Announces New Memoir "Mi Vida Loca: Tales of a NuyoRican"
- Yesyal Launches Official Website, Unifying Music, Film, and Apparel Under One Independent Brand
- Avalex, LP & Avalex Ent Announces Professional Services and Evaluations for Entertainment, Sports
- High-End Exterior House Painting in Boulder, Colorado
- Meet a Scientologist Grills Up Gold Viddy Award for Japan's Gourmet Burger Pioneer Akio Kitaura
- Simpson and Reed Co-Founders Shardé Simpson, Esq. and Ciara Reed, Esq. Launch "Hello Wilma,"
- Report Outlines Key Questions for Individuals Exploring Anxiety Treatment Options in Toronto
- Rande Vick Introduces Radical Value, Challenging How Brands Measure Long-Term Value
- Lisa Mauretti Launches Peace of Mind Travel Coaching to Guide Fearful Travelers to Discover the World with Confidence
- New Year, New Home: Begin 2026 at Heritage at South Brunswick
- Higginswerx Honored as Winner in FlovaAI Christmas Creator Challenge
- Food Journal Magazine Releases Its 'Best Food In Los Angeles Dining' Editorial Section
- Enders Capital: 25% Gains with Just -0.80% Maximum Monthly Drawdown in Volatile Debut Year 2025
- Max Weinberg Brings His Max Weinberg's Jukebox to the Weinberg Center
- Venture Beyond the Ordinary in "AJ AND THE INCREDIBLE FISH" by Paolo Mazzucato
- CES Spotlight Highlights Need for Strategic Review as Throughput Demands Evolve
- ASR Media, Social T Marketing & PR Announce Merger
- $780,000 Project for New Middle East Police Service with Deposit Received and Preliminary Design Work Underway for Lamperd: Stock Symbol: LLLI